DHX9 and hepatocellular carcinoma: Thus, we speculated HBV may inhibit the ubiquitin-proteasome degradation of DHX9 by phosphorylating UHRF2 at serine 643, and upregulating DHX9 protein levels to promotes HBV replication and HCC development.